How to buy Fulgent Genetics stock

Fulgent Genetics, Inc is a diagnostics & research business based in the US. Fulgent Genetics shares (FLGT) are listed on the NASDAQ and all prices are listed in US Dollars. Fulgent Genetics employs 473 staff and has a trailing 12-month revenue of around USD$135.1 million.

How to buy shares in Fulgent Genetics

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Fulgent Genetics. Find the stock by name or ticker symbol: FLGT. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fulgent Genetics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Fulgent Genetics, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Fulgent Genetics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Fulgent Genetics share price

Use our graph to track the performance of FLGT stocks over time.

Fulgent Genetics shares at a glance

• Key figures

Information last updated 2021-02-23.

52-week range	USD$6.7 - USD$189.89
50-day moving average	USD$104.0388
200-day moving average	USD$56.1039
Wall St. target price	USD$85
PE ratio	50.7944
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$2.14

Buy Fulgent Genetics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Fulgent Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Fulgent Genetics, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Fulgent Genetics financials

Revenue TTM	USD$135.1 million
Operating margin TTM	47.25%
Gross profit TTM	USD$18.4 million
Return on assets TTM	25.87%
Return on equity TTM	39.51%
Profit margin	35.31%
Book value	$8.021
Market capitalisation	USD$2.6 billion

TTM: trailing 12 months

Shorting Fulgent Genetics shares

There are currently 4.2 million Fulgent Genetics shares held short by investors – that's known as Fulgent Genetics's "short interest". This figure is 0.8% up from 4.1 million last month.

There are a few different ways that this level of interest in shorting Fulgent Genetics shares can be evaluated.

Fulgent Genetics's "short interest ratio" (SIR)

Fulgent Genetics's "short interest ratio" (SIR) is the quantity of Fulgent Genetics shares currently shorted divided by the average quantity of Fulgent Genetics shares traded daily (recently around 2.5 million). Fulgent Genetics's SIR currently stands at 1.68. In other words for every 100,000 Fulgent Genetics shares traded daily on the market, roughly 1680 shares are currently held short.

However Fulgent Genetics's short interest can also be evaluated against the total number of Fulgent Genetics shares, or, against the total number of tradable Fulgent Genetics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fulgent Genetics's short interest could be expressed as 0.17% of the outstanding shares (for every 100,000 Fulgent Genetics shares in existence, roughly 170 shares are currently held short) or 0.2898% of the tradable shares (for every 100,000 tradable Fulgent Genetics shares, roughly 290 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Fulgent Genetics.

Find out more about how you can short Fulgent Genetics stock.

Fulgent Genetics share price volatility

Over the last 12 months, Fulgent Genetics's shares have ranged in value from as little as $6.7 up to $189.89. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fulgent Genetics's is 1.6935. This would suggest that Fulgent Genetics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Fulgent Genetics overview

Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home Covid-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Frequently asked questions

• What percentage of Fulgent Genetics is owned by insiders or institutions?

  Currently 41.143% of Fulgent Genetics shares are held by insiders and 34.787% by institutions.

• How many people work for Fulgent Genetics?

  Latest data suggests 473 work at Fulgent Genetics.

• When does the fiscal year end for Fulgent Genetics?

  Fulgent Genetics's fiscal year ends in December.

• Where is Fulgent Genetics based?

  Fulgent Genetics's address is: 4978 Santa Anita Avenue, Temple City, CA, United States, 91780

• What is Fulgent Genetics's ISIN number?

  Fulgent Genetics's international securities identification number is: US3596641098

• What is Fulgent Genetics's CUSIP number?

  Fulgent Genetics's Committee on Uniform Securities Identification Procedures number is: 359664109